Quick Answer
Phosphatidylserine Cognitive Stress Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Conclusions Under the present 14-day experimental conditions, the multi-ingredient protocols containing taurine, caffeine, and phosphatidylserine were associated with more favorable selected cognitive and psychomotor outcomes, 30 m sprint performance, and baseline-adjusted GPS-derived locomotor outcomes than placebo.
Key Takeaways
- 01Conclusions Under the present 14-day experimental conditions, the multi-ingredient protocols containing taurine, caffeine, and phosphatidylserine were associated with more favorable selected cognitive and psychomotor outcomes, 30 m sprint performance, and baseline-adjusted GPS-derived locomotor outcomes than placebo. [Mizera K (2026)]
- 02Background/objectives Cognitive fatigue and impaired psychomotor function may contribute to reductions in football-specific performance during prolonged match-like activity. [Mizera K (2026)]
- 03This study evaluated cognitive, psychomotor, sprint, and football-specific locomotor responses to multi-ingredient protocols containing taurine, caffeine, and either 300 or 600 mg·day -1 of phosphatidylserine in professional male football players. [Mizera K (2026)]
- 04The second study confirmed the GBP benefits on mood states and a visually consistent downward trend in reaction times across all four cognitive performance tests at both GBP dosages, suggesting improved processing speed in response to various stimuli. [Hawkins K (2026)]
The current Migaku evidence database contains 2 reusable source documents for Phosphatidylserine Cognitive Stress Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- Conclusions Under the present 14-day experimental conditions, the multi-ingredient protocols containing taurine, caffeine, and phosphatidylserine were associated with more favorable selected cognitive and psychomotor outcomes, 30 m sprint performance, and baseline-adjusted GPS-derived locomotor outcomes than placebo. [Mizera K (2026); evidence level 2]
- Background/objectives Cognitive fatigue and impaired psychomotor function may contribute to reductions in football-specific performance during prolonged match-like activity. [Mizera K (2026); evidence level 2]
- This study evaluated cognitive, psychomotor, sprint, and football-specific locomotor responses to multi-ingredient protocols containing taurine, caffeine, and either 300 or 600 mg·day -1 of phosphatidylserine in professional male football players. [Mizera K (2026); evidence level 2]
- The second study confirmed the GBP benefits on mood states and a visually consistent downward trend in reaction times across all four cognitive performance tests at both GBP dosages, suggesting improved processing speed in response to various stimuli. [Hawkins K (2026); evidence level 2]
- Mental health is threatened every day by the stressors of life: frenetic work rhythms, stressful conditions can generate anxiety, depression, cognition, and sleep problems. [Hawkins K (2026); evidence level 2]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Football-Specific Performance and Cognitive Fatigue Resistance Following Supplementation with Two Phosphatidylserine Doses Combined with Taurine and Caffeine in Professional Male Football Players: A Randomized, Triple-Masked, Placebo-Controlled Trial.
- Health Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.